Health
77.8% efficacy claimed by Bharat Biotech in the final analysis for Covaxin
The indigenous vaccine against the coronavirus disease Covaxin has said to be completed with its final phase 3 analysis as…
Tag
Covaxin
Health
Health
Bharat Biotech over Covaxin deal row: No payment received from Brazil govt, ‘step-by-step’ approach followed
"As of 29th June 2021, Bharat Biotech has not received any advance payments nor supplied any vaccines to Ministry of…
Health
Covaxin can neutralise Delta COVID-19 variant, says US National Institute of Health
The conclusion was reached on the basis of two studies conducted on the blood serum of people who were vaccinated…
India
India hopes that countries normalize travel with it soon
On Thursday, India urged countries to normalize travel with India since they had started the travel bubble and cut travel…
Companies
Bharat Biotech’s Covaxin phase 3 trials efficacy data approved by SEC
Bharat Biotech phase 3 trials efficacy data has been approved by the Subject Expert Committee (SEC). As per CNBC TV18…
Health
Bharat Biotech submits Covaxin’s phase 3 trial data to DCGI
A Subject Expert Committee (SEC) under the drugs regulator is likely to meet today to evaluate and discuss the results…
Health
Bharat Biotech says Rs150 per dose of Covaxin is “not sustainable”
The Hyderabad-based company said that it should be allowed to maintain a differential pricing strategy for the government hospitals and…
Health
Good News: Delhi AIIMS to start trail on children from June, 15, 2021
Delhi's All India Institute of Medical Sciences is expected to begin on Tuesday the recruitment and clinical trials of India's…
Health
Trials to be conducted in the United States by Bharat Biotech
To support the marketing application for COVAXIN, Bharat Biotech will be conducting clinical trials in the United States, according to…
Health
Covaxin’s third phase trial data will be published in 7-8 days: Govt
The crucial phase 3 trial data of Bharat Biotech’s Covaxin, detailing the efficacy of the indigenous COVID-19 vaccine produced by…
Health
Covaxin being denied emergency approval in US will not hinder India’s vaccine plan, mentions centre
Bharat Biotech’s Covaxin has been denied by the FDA for emergency use in the United States of America. The US…
Health
US FDA denies emergency authorization for Covaxin, asks for more data
The FDA's rejection of an interim approval will delay Bharat Biotech's plan to export its vaccine to the United States.